Table 3.
Lipid Parameters of Dyslipidemia Patients Before Switching Treatment from Brand-Name to Generic Atorvastatin and 6 Months After Stratified by Age
| Factors | Baseline | 6th Month | Mean Differences | 95% CI | p value |
|---|---|---|---|---|---|
| Age | |||||
| < 60 (n = 216) | |||||
| Chol | 180.85 (54.92) | 170.04 (46.24) | −9.58 | −15.38, −3.78 | 0.001 |
| Tg | 149.82 (75.60) | 157.17 (91.39) | 4.10 | −7.11, 15.31 | 0.471 |
| HDL | 52.08 (13.71) | 49.21 (12.75) | −2.39 | −3.74, −1.04 | < 0.001 |
| LDL | 115.66 (49.73) | 103.76 (40.51) | −11.90 | −16.76, −7.04 | < 0.001 |
| ≥ 60 (n = 272) | |||||
| Chol | 169.43 (43.30) | 162.00 (40.07) | −7.18 | −12.96, −1.39 | 0.015 |
| Tg | 137.95 (63.12) | 137.44 (63.86) | −1.01 | −9.37, 7.33 | 0.810 |
| HDL | 51.38 (13.47) | 49.24 (13.21) | −1.89 | −3.24, −0.54 | 0.006 |
| LDL | 105.65 (39.85) | 98.42 (44.87) | −7.23 | −12.64, −1.81 | 0.009 |
Abbreviations: CI, confidence interval; Chol, cholesterol (mg/dL); Tg, triglyceride (mg/dL); HDL, high-density lipoprotein-cholesterol (mg/dL); LDL, low-density lipoprotein-cholesterol (mg/dL).